Corporate News
Bgi Genomics (300676.SZ)
- Trading performance (24 h ending 07:56 AM CET, 21 Oct 2026): flat 0 %.
- Current price: CNY 40.96.
- Shares outstanding: 390.5 million.
- Market capitalization: CNY 15.1 billion.
- Volume traded in last 24 h: CNY 346.5 million.
- Change since last month‑end: –8.52 %.
- 200‑day simple moving average: CNY 38.12.
- 52‑week range: high CNY 65 (13 Jan 2026), low CNY 32.55 (11 Jun 2026).
Peer performance (last 24 h)
| Company | Ticker | Trading % | Current price | Market cap | P/E (if available) |
|---|---|---|---|---|---|
| China Petroleum Engineering | 600339.SS | flat 0 % | CNY 3.22 | CNY 18.2 bn | 72.22 |
| North Navigation Control T | 600435.SS | flat 0 % | CNY 12.67 | CNY 18 bn | – |
| Kangmei Pharmaceutical | 600518.SS | flat 0 % | CNY 1.29 | CNY 18 bn | 541.67 |
| Meinian Onehealth Healthcare | 002044.SZ | flat 0 % | CNY 4.92 | CNY 18.1 bn | 59.13 |
| Autobio Diagnostics | 603658.SS | flat 0 % | CNY 34.27 | CNY 18 bn | 18.72 |
Company Overview
Bgi Genomics Co., Ltd., headquartered in Shenzhen, China, specializes in DNA, RNA, and customized sequencing services. The firm offers a broad portfolio of genetic tests to medical and research institutions, including non‑invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing. Bgi Genomics also provides oncology solutions and engages in research across agriculture, food science, cancer, metagenomics, reproductive health, biomarker discovery, and drug development.
Founded in 1999 as Shenzhen BGI Medicine Co., Ltd., the company rebranded to Bgi Genomics Co., Ltd. in 2015. It is listed on the Shenzhen Stock Exchange and operates worldwide, with a website at www.bgi.com .
Note: All figures are current as of the market close on 21 Oct 2026.